Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.
By P. Menasché, A. Hagège, J. Vilquin, M. Desnos, E. Abergel, B. Pouzet, A. Bel, S. Sarateanu, M. Scorsin, K. Schwartz and 4 more. Journal of the American College of Cardiology, 2003
1,189 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/64ffd2dfe1a8aac3498d678ccc785d0d82e3028e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Stefanie Dimmeler
- A. Zeiher
- Y. Yoon
- M. Pittenger
- A. Wecker
- B. Martin
- Douglas Losordo
- Lindsay Heyd
Citations in the corpus
- Unchain my heart: the scientific foundations of cardiac repair. (2005, background): “org Volume 115 Number 3 March 2005 implantable cardioverter/defibrillator, as a mandatory adjunct to therapy (47).”
- Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart (2004, methodology): “Isolated primary neonatal rat cardiomyocytes were used as described (3, 16-6, 7) for co-culture with human CSs.”
- Mesenchymal stem cells and their potential as cardiac therapeutics. (2004, background): “The hMSCs, with their attributes of (1) ease of isolation, (2) high expansion potential, (3) genetic stability, (4) reproducible attributes from isolate to isolate, (5) reproducible characteristics in widely dispersed laboratories, (6) compatibility with tissue engineering principles, and (7) potent”
- Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. (2005, background): “In this regard it is noteworthy that the arrhythmic events that have been reported thus far have occurred following skeletal myoblast transplantation (49), while no events have been reported following transplantation of BM or circulating cells.”